These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38162389)

  • 1. Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma.
    Wei Q; Hou YC; Mao FF; Feng JK; Wang X; Cheng SQ
    Hepat Med; 2023; 15():249-264. PubMed ID: 38162389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC.
    Jia X; Wang Y; Yang Y; Fu Y; Liu Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
    Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma.
    Zhu Y; Jin X; Liu J
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38639274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
    Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
    J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
    Zhang H; Wang J; Yang M
    Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma.
    Pu L; Sun Y; Pu C; Zhang X; Wang D; Liu X; Guo P; Wang B; Xue L; Sun P
    Sci Rep; 2024 Feb; 14(1):4354. PubMed ID: 38388539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma.
    Guo Z; Xie Y; Zhang L; Liu S; Jiang W
    Aging (Albany NY); 2024 Jan; 16(1):267-284. PubMed ID: 38180745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting colorectal cancer prognosis based on long noncoding RNAs of disulfidptosis genes.
    Wang KL; Chen KD; Tang WW; Chen ZP; Wang YJ; Shi GP; Chen YG
    World J Clin Oncol; 2024 Jan; 15(1):89-114. PubMed ID: 38292658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening.
    Wang H; Wang W
    Open Med (Wars); 2024; 19(1):20240919. PubMed ID: 38584823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel disulfidptosis-related lncRNAs signature in patients with HPV-negative oral squamous cell carcinoma.
    Yang F; Niu X; Zhou M; Li W
    Sci Rep; 2024 Jun; 14(1):14436. PubMed ID: 38910181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma.
    Xu L; Chen S; Li Q; Chen X; Xu Y; Zhou Y; Li J; Guo Z; Xing J; Chen D
    Cancer Cell Int; 2024 Jan; 24(1):30. PubMed ID: 38218909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.
    Mulati Y; Lai C; Luo J; Hu J; Xu X; Kong D; Xiao Y; Liu C; Xu K
    BMC Cancer; 2024 Jan; 24(1):44. PubMed ID: 38191330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer.
    Xiao L; Yin W; Chen X; Zhang X; Zhang C; Yu Z; Lü M
    Sci Rep; 2023 Nov; 13(1):20135. PubMed ID: 37978247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer.
    Zhu J; Wu Y; Ji P; Qi J; Yang X; Pocha C; Tustumi F; Biachi de Castria T
    J Gastrointest Oncol; 2024 Aug; 15(4):1647-1656. PubMed ID: 39279954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.
    Kang K; Li X; Peng Y; Zhou Y
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature.
    Chen C; Wang C; Li Y; Jiang S; Yu N; Zhou G
    Sci Rep; 2024 Mar; 14(1):7157. PubMed ID: 38531953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer.
    Xing F; Qin Y; Xu J; Wang W; Zhang B
    Mol Biotechnol; 2024 Sep; 66(9):2396-2414. PubMed ID: 37733182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.